Psychiatric Deprescribing: Case Studies and Clinical Implications in Forensics: Psychiatric Deprescribing

Kerri A. Ellis; Shari L. Harding; Victor Petreca

doi:10.29173/jafn795

Authors

Kerri A. Ellis University of Rhode Island https://orcid.org/0009-0008-3175-0812
Shari L. Harding https://orcid.org/0000-0002-7427-1116
Victor Petreca Boston College Connell School of Nursing https://orcid.org/0000-0003-1080-2632

DOI:

https://doi.org/10.29173/jafn795

Keywords:

person-centered care, polypharmacy, psychiatric deprescribing, forensic nurses and advanced practice nurses

Abstract

The use of psychiatric medications is highly individualized. Polypharmacy is common, often introducing additional risks with limited benefits. In correctional settings, judicious use of psychiatric medications is critically important. During transitions of care, such as admission to a correctional facility, individuals benefit from timely and evidence-based prescriptive practices. Various factors can impact the continuation of treatment and medication access for incarcerated individuals, including communication gaps between community clinicians and correctional medical teams, formulary options, structured medication administration schedules, substance misuse, feigned illness, and diversion. Forensic nurses and advanced practice nurses navigate these complexities to provide effective and safe medication plans for incarcerated individuals. Incarceration presents an opportunity to review and deprescribe medications that are excessively or inappropriately prescribed. The existing psychiatric deprescribing literature is limited, with even less evidence oriented towards forensic settings. This paper utilizes case studies of incarcerated individuals to explore clinical insights and experiences related to deprescribing.

Author Biography

Victor Petreca, Boston College Connell School of Nursing

Assistant Professor and Program Director

References

Aggarwal, N. K., & Lewis-Fernández, R. (2015). Clinical synthesis: An introduction to the Cultural Formulation Interview. Focus, 13, 426–431. doi:10.1176/appi.focus.20150016

American Academy of Psychiatry and the Law. (2018). AAPL Practice Resource for Prescribing in Corrections. Journal of the American Academy of Psychiatry and the Law Online, 46(2 Supplement), S2-S50.

Appelbaum KL: The mental health professional in a correctional culture, in Handbook of Correctional Mental Health. Edited by Scott CL. Washington, DC: American Psychiatric Publishing, 2010, pp 91–118

Berg, S. A., & Moss, J. H. (2022). Anchoring and judgment bias: Disregarding under uncertainty. Psychological Reports, 125(5), 2688-2708. https://doi.org/10.1177/00332941211016750

Chapter 3. Developing Change: Designing the Medication Reconciliation Process. Content last reviewed July 2022. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/patient-safety/settings/hospital/match/chapter-3.html

Clercx, M., & van Pinxteren, L. (2024). Don't beat around the bush! The relationship between forensic vigilance and communication style. International Journal of Offender Therapy and Comparative Criminology, 68(2), 129-145. https://doi.org/10.1177/0306624X241228214

Edinoff A, Ruoff MT, Ghaffar YT, Rezayev A, Jani D, Kaye AM, Cornett EM, Kaye AD, Viswanath O, Urits I. (2020). Cariprazine to treat schizophrenia and bipolar disorder in adults. Psychopharmacology Bulletin, 50(4):83-117.

Fay, C., Bonsergent, M., Saillard, J., Huon, J.-F., & Prot-Labarthe, S. (2024). Exploration of the barriers and enablers of benzodiazepines deprescribing in prisons: A qualitative study among health and social care professionals. Basic Clin Pharmacol Toxicol, 134(1), 28–38.

Fineberg, S. K., Gupta, S., & Leavitt, J. (2019). Collaborative deprescribing in borderline personality disorder: A narrative review. Harvard Review of Psychiatry, 27(2), 75–86.

Gonzalez, J. M. R., & Connell, N. M. (2014). Mental health of prisoners: Identifying barriers to mental health treatment and medication continuity. American Journal of Public Health, 104(12), 2328–2333. https://doi.org/10.2105/AJPH.2014.302043.

Gupta, S., & Cahill, J. D. (2016). A prescription for “deprescribing” in psychiatry. Psychiatric Services, 67(8), 904-907.

Gupta, S., Miller, R., & Cahill, J. D. (2019). Deprescribing in Psychiatry. Oxford University Press.

Harding SL, Ellis KA, Boisseau J, Petreca V. Psychiatric deprescribing: A narrative review. Journal of the American Psychiatric Nurses Association. 2023;0(0). doi:10.1177/10783903231185353

Jennings L, Branson CF, Maxwell AM, Winkelman TNA, Shlafer RJ. (2021) Physicians’ perspectives on continuity of care for patients involved in the criminal justice system: A qualitative study. PLoS ONE 16(7): e0254578. https://doi.org/ 10.1371/journal.pone.0254578

Kouijzer, M. T. E., Kip, H., & Kelders, S. M. (2024). Introduction of virtual reality in forensic mental healthcare: An interview study on the first impressions of patients and healthcare providers regarding VR in treatment. Frontiers in Psychology, 15, 1284983. https://doi.org/10.3389/fpsyg.2024.1284983

Lin S. K. (2020). Antipsychotic polypharmacy: A dirty little secret or a fashion? The International Journal of Neuropsychopharmacology, 23(2), 125–131. https://doi.org/10.1093/ijnp/pyz068

Machetanz, L., Hofmann, A. B., & Möhrke, J. (2023). Offenders and non-offenders with schizophrenia spectrum disorders: The crime-preventive potential of sufficient embedment in the mental healthcare and forensic psychiatric care. Frontiers in Psychiatry, 14, 1231851. https://doi.org/10.3389/fpsyt.2023.1231851

Neumann, L., & Neumann, M. (2024). Unsupervised short leave in forensic addiction treatment: Is there an influence on treatment progress? Monatsschrift für Kriminologie und Strafrechtsreform, 107(1), 78-93. https://doi.org/10.1515/mks-2023-0041

Paudel, S., Vyas, C. M., & Stern, T. A. (2020). A prescription for deprescribing antipsychotics: Managing polypharmacy in schizophrenia. The Primary Care Companion for CNS Disorders, 22(6). https://doi.org/10.4088/PCC.20f02708

Scholten, W., Batelaan, N., & Van Balkom, A. (2020). Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations. Therapeutic Advances in Psychopharmacology, 10, 2045125320933404.

Soler, J., Casellas-Pujol, E., Fernández-Felipe, I., Martín-Blanco, A., Almenta, D., & Pascual, J. C. (2022). "Skills for pills": The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder. Acta psychiatrica Scandinavica, 145(4), 332–342.

Stutzman D. L. (2021). Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing. The Mental Health Clinician, 11(6), 320–333.

Tomova, N., Hale, A., & Kruschandl, M. (2021). Deprescribing in mental health: Pragmatic steps for a better quality of life. Journal of Prescribing Practice, 3(2), 60-66.

Psychiatric Deprescribing: Case Studies and Clinical Implications in Forensics